EveryDayMeds offers UK adults private online access to Mounjaro (tirzepatide) through a prescription service that includes a clinical assessment, dispensing from a GPhC-registered pharmacy, and temperature-controlled home delivery.
If you are comparing providers for prescription weight management treatment, the first question is usually the practical one: what does it actually cost?
The honest answer is that the price depends on your dose, your provider, and what is bundled into the advertised fee.
This guide explains how Mounjaro works, who may be eligible, how UK pricing is structured, how NHS and private access differ, why availability can change, what ordering, delivery, and storage involve, and how Mounjaro compares with other treatments.
This may help you make a safe, informed, and cost-effective decision before committing to a provider.
What Mounjaro Is and How It Works
Mounjaro is the brand name for tirzepatide, manufactured by Eli Lilly. It is a dual GIP and GLP-1 receptor agonist, meaning it acts on two gut hormone pathways rather than one. Those pathways influence appetite signalling, how quickly the stomach empties, and how the body regulates blood glucose.
In practical terms, most people describe reduced appetite and earlier fullness during meals. It is given as a once-weekly injection under the skin using a pre-filled pen.
Tirzepatide holds MHRA marketing authorisation in the UK for two separate indications: weight management alongside diet and physical activity, and type 2 diabetes. The licensed indication matters, because it affects both who can be prescribed it and how it is funded.
Mounjaro treatment is a prescription medicine. It cannot be sold over the counter, and any UK source offering it without a clinical assessment is operating outside the law. Treatment suitability depends on an individual clinical assessment, and your prescriber will determine whether it is appropriate for you.
The Clinical Evidence
Tirzepatide's weight management evidence comes from the SURMOUNT programme.
SURMOUNT-1 enrolled 2,539 adults with obesity, or with overweight plus at least one weight-related condition, and without type 2 diabetes. In practical terms, this helps explain how does Mounjaro produce measurable change over time: it reduces appetite, slows stomach emptying, supports regulating blood sugar and regulating blood sugar levels, and can help you feel full earlier, which may reduce calorie intake.
Over 72 weeks, participants on tirzepatide experienced substantially greater average weight reduction than those on placebo, with results increasing across the dose range studied, although individual results still vary by starting weight and how much weight someone needs to lose. In these clinical trials, 91% of participants could expect to lose at least 5% of body weight, and some people may notice the effect begin from the first dose when treatment is paired with lifestyle changes.
The trial was published in the New England Journal of Medicine in 2022. Together, these effects support weight loss when used alongside lifestyle changes.
SURMOUNT-2 studied adults with obesity and type 2 diabetes, a group that typically sees smaller reductions than those without diabetes, so the weight loss seen with Mounjaro can also support management of type 2 diabetes.
SURMOUNT-4 examined what happens after the initial phase. Participants completed an open-label lead-in and were then randomised either to continue tirzepatide or switch to placebo. Those who stopped regained a meaningful proportion of the weight they had lost, which matters when planning treatment around a goal weight.
One important finding is that Mounjaro works while you are taking it. Many people regain some of the weight they have lost after stopping treatment, so long-term success also depends on maintaining healthy lifestyle habits. Common side effects are usually most noticeable when starting treatment or after a dose increase and often improve within a few weeks.
How Much Does Mounjaro Cost Per Month in the UK?
Private Mounjaro pricing in the UK is set by individual pharmacies, so there is no single national price.
Two factors affect the price you pay.
1-Dose strength-
Mounjaro treatment starts at the lowest strength: the starting dose of mounjaro is 2.5mg once weekly. If appropriate, your prescriber may increase the dose in 2.5mg steps every four weeks up to 15mg.
Higher strength pens generally cost more than lower-strength pens, so the price of treatment often increases as your dose increases. This means the price of your starting dose may not be the same several months later.
2- What's included.
Some prices cover only the mounjaro pen. Others include consultation, prescriber review, needles, sharps disposal and delivery. Each pen contains four weekly doses, which is why per-pen and per-month pricing are often the same, though you should still check. As a weight loss drug, Mounjaro is usually priced not just around the medicine itself but around the clinical support that comes with treatment. When comparing providers, check what's included, as a lower advertised price may not always represent the lowest overall cost.
The cost trajectory most price pages skip
| Treatment stage | What changes | Cost effect |
|---|---|---|
| Initial dose | Lowest strength, starting point for everyone starting treatment with this weight loss medication | Lowest monthly cost |
| Escalation phase | Dose increased in steps if tolerated and appropriate, usually gradually to improve tolerability and manage side effects early on | Cost rises at each step |
| Maintenance | Prescriber-determined dose held steady | Settles at the higher end |
| Ongoing | Continued while clinically appropriate | Recurring, not one-off |
Budgeting UK private pricing for this weight loss drug on the starting price is the most common mistake people make. A realistic plan for your weight loss journey accounts for the maintenance dose, not month one.
Longer-term planning should also reflect that not everyone moves up to the maximum maintenance dose.
People using insulin or sulfonylureas alongside some diabetes medications need extra prescriber oversight because the risk of low blood sugar is higher.
What to check in any advertised price
- Does it include the online consultation and prescriber review?
- Are needles and a sharps bin included, or charged separately?
- Is delivery included, and is it temperature-controlled?
- Is it a genuine per-month figure, or a per-pen figure where a month needs more than one pen?
- Does the price page or support material explain what to do after a missed dose, including that it should be taken within 96 hours?
- Are there subscription lock-ins or cancellation terms?
- Does the price include follow-up clinical reviews if your dose changes?
- Does the provider give clear guidance on using Mounjaro safely, including what to do if you miss a dose or need to change your injection day?
NHS Versus Private Access
NICE recommends tirzepatide as an option for managing overweight and obesity on the NHS, within specific eligibility criteria set out in its guidance. NHS England has implemented this through a phased rollout, prioritising those with the highest clinical need first.
In practice, NHS access remains limited in many areas, and waiting times can vary depending on local services. As a result, many eligible adults choose to access treatment through a regulated private provider instead.
| NHS route | Private route | |
|---|---|---|
| Cost to patient | Prescription charge only, or free if exempt | Full cost of medicine plus service |
| Eligibility | NICE criteria, with eligible patients typically needing a BMI of 30 or above, though a weight related health condition may also matter under current guidance | Provider assessment against clinical criteria |
| Access speed | Phased rollout, waits common | Usually days after assessment |
| Oversight | NHS specialist weight management services | Registered pharmacy prescriber |
| Availability | Subject to local commissioning | Subject to supply |
If you think you may qualify on the NHS, it is worth speaking to your GP before assuming private is the only option. Private prescribers also commonly assess whether adults meet a BMI of 30 or higher before approval, alongside factors such as high blood pressure. Eligibility criteria and rollout stages should be checked against current NICE and NHS England guidance, as both have changed since initial publication.
Why Prices Vary Between Pharmacies
Genuine reasons prices differ:
Purchasing terms. Pharmacies buy at different volumes on different terms.
Service model. A price including prescriber time, follow-up reviews and packaged delivery costs more to deliver than a medicine-only price.
Included consumables. Needles and sharps disposal are small individually but add up.
Delivery method. Temperature-controlled shipping costs more than standard post, and matters for a medicine requiring refrigeration.
If a price seems unusually low, it is worth checking what is included and whether the provider follows the appropriate prescribing process.
Verifying a UK provider
Before ordering, check that the provider:
- Is registered with the General Pharmaceutical Council’
- Requires a genuine clinical assessment before any prescription.
- Has a named prescriber responsible for the decision.
- Has a UK-based operation with a physical address and contact details.
- Does not offer Mounjaro without a prescription
Any UK website offering Mounjaro without a clinical assessment and prescriber approval should be treated with caution.
Availability and Supply
Availability has fluctuated since launch. Demand has at times exceeded manufacturing capacity for GLP-1 medicines, and specific dose strengths have been intermittently constrained.
Two practical implications. First, availability can differ by strength, so a pharmacy may hold some doses and not others. Second, supply affects continuity, which matters because interruptions to treatment can mean restarting at a lower dose under prescriber guidance.
The MHRA and the Department of Health and Social Care publish supply notifications when disruptions are anticipated. Ask a prospective provider directly how they handle supply gaps and whether they can confirm stock of the strength you would move to next.
Storage and Delivery
Mounjaro requires refrigerated storage. The Summary of Product Characteristics sets out the storage range and the limited period the pen may be kept below a specified temperature outside the fridge, along with in-use limits after first use.
This is why cold-chain delivery matters. A pen shipped in ordinary packaging in summer may not have been kept within its storage range, and there is usually no way to tell from the outside. Ask how a provider ships and what they do if a delivery is delayed or arrives warm.
Do not freeze the pen. If it has frozen, it should not be used. Always follow the storage instructions in the Patient Information Leaflet supplied with your medicine.
Eligibility
Prescribers assess against criteria that typically include BMI thresholds, the presence of weight-related health conditions, medical history, current medications and previous weight management attempts.
Certain medical conditions and circumstances mean tirzepatide may not be suitable. These include pregnancy, breastfeeding, type 1 diabetes, certain thyroid conditions, severe allergic reactions and some other medical conditions or medicines.
This is why it is important to answer every question during your consultation honestly and completely.
The Ordering Process
- Online consultation.
A health questionnaire covering medical history, current medications, BMI, previous weight management attempts, and screening for common contraindications that may affect suitability. - Prescriber review.
An independent prescriber assesses the information. They may request clarification, further evidence, or decline if criteria are not met. This review checks specific exclusions, including that Mounjaro is not approved for use in type 1 diabetes, is not recommended during pregnancy or breastfeeding, and is contraindicated for people with a personal or family history of certain thyroid cancers. A history of severe allergic reactions to this type of medicine, or some diabetes-related complications such as diabetic retinopathy, may also need extra review or make treatment unsuitable. - Prescription and dispensing.
If approved, the prescription is dispensed by the registered pharmacy. - Delivery.
Dispatched in temperature-controlled packaging, with the patient information leaflet included for safety details and instructions on how to inject mounjaro, including site rotation and whether the abdomen, thigh, or upper arm is suitable. - Ongoing review.
Ongoing treatment usually includes regular reviews, particularly if your dose changes.
Common side effects include nausea, diarrhoea and constipation. These often improve as your body adjusts. Serious side effects are uncommon but require prompt medical attention.
Timescales vary. Assessment often completes within a day or two, with delivery following. Any provider offering Mounjaro without a genuine clinical assessment should be treated with caution.
Comparing Treatment Options
Mounjaro is one of several licensed weight loss injections used in weight management. Others include semaglutide-based treatments, other weight loss injections, and, for some people, non-injectable approaches. They differ in mechanism, dosing schedule, evidence base and cost.
No treatment is universally better than another.
In comparative evidence, mounjaro for weight loss has shown stronger average weight loss than some alternative weight loss treatments, including certain injectable options, but the right choice still depends on your clinical picture, other conditions, tolerability and what you can sustain. Your prescriber will determine the appropriate treatment based on your individual assessment.
Whichever route you consider, it works alongside a healthy diet, a reduced-calorie diet, regular exercise, and a consistent diet and exercise plan rather than replacing them. The trial evidence reflects treatment delivered with lifestyle support, and outcomes outside that context may differ.
